Although the dPCR is not yet routinely applied for the standard analysis of molecular MRD in CML, preliminary data suggest that it is more sensitive and accurate than RT‐qPCR for monitoring the BCR‐ABL1 transcript levels and, possibly, for predicting the patients who are going to relapse after discontinuation of TKI.24 This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.